Browsing by Titles

Showing results 1 to 7 of 7

  • Beom Yong Lee
  • 2022
  • Beom Yong Lee. (2022). Development of a GFRAL antagonistic antibody for the amelioration of cancer cachexia. doi: 10.22677/thesis.200000593969
  • DGIST
  • View : 371
  • Download : 0
  • Jongwon Jeong
  • 2024
  • Jongwon Jeong. (2024). Development of bio-therapeutics for intractable disease: GFRAL antagonist antibody for alleviating chemotherapy-induced cachexia & Primed MSC-sEV for amelioration of COVID-19-induced ARDS. doi: 10.22677/THESIS.200000798073
  • DGIST
  • View : 60
  • Download : 0
  • Inseong Jung
  • 2024
  • Inseong Jung. (2024). Development of novel therapeutics and exploration of strategy to enhance their efficacy for advancing cancer immunotherapy. doi: 10.22677/THESIS.200000799931
  • DGIST
  • View : 66
  • Download : 0
  • Jungin Lee
  • 2022
  • Jungin Lee. (2022). Discovering therapeutic target genes for neovascular diseases using a pooled CRISPR screen targeting cell membrane proteins. doi: 10.22677/thesis.200000595184
  • DGIST
  • View : 363
  • Download : 0
  • JunHee Kim
  • 2024
  • JunHee Kim. (2024). Screening and functional characterization of extra-nasal odorant receptor antagonists. doi: 10.22677/THESIS.200000805501
  • DGIST
  • View : 42
  • Download : 0
  • Sanghee Shin
  • 2024
  • Sanghee Shin. (2024). T cell-derived extracellular vesicles for cancer immunotherapy. doi: 10.22677/THESIS.200000798011
  • DGIST
  • View : 64
  • Download : 0
  • Eunju Park
  • 2025
  • Eunju Park. (2025). T cell-derived small extracellular vesicles targeting CD24 enhance anti-tumor effect through dual activation of innate and adaptive immunity. doi: 10.22677/THESIS.200000829162
  • DGIST
  • View : 56
  • Download : 0
1